Altered glutamate regulation in gray matter (GM) has been implicated in the pathogenesis of cognitive impairment in multiple sclerosis (MS), but such pathology in GM is subtle and difficult to detect using conventional MRI techniques. In this work, we apply a quantitative, glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI technique at 7.0T to gain new insights into molecular changes underlying GM pathology and their relationship to cognitive impairment in MS. We found significant differences in cortical GM GluCEST contrast between healthy controls and patients with MS, and in some cortical regions, GluCEST contrast correlates significantly with measures of cognitive impairment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords